INNOMED-UP BLOG
CONGRESS GUIDE
A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices | npj Primary
70+ "Ioannis M.d" profiles | LinkedIn
70+ "Ioannis M.d" profiles | LinkedIn
Ioannis Kottakis MD,PhD,FCCP – Global Medical Head asthma – Novartis Pharma AG | LinkedIn
Press Releases Archives - Page 2 of 4 - Averof II
PDF) Edry™: An Innovative Dry Powder Technology Evaluated via Functional Respiratory Imaging.
Opsis Clinical | Medipass
10+ "Ioannis" profiles | LinkedIn
Opsis Clinical | Medipass
70+ "Ioannis M.d" profiles | LinkedIn
Ioannis SANIDAS | Instructor | PhD | Harvard Medical School, MA | HMS | Department of Medicine
10+ "Ioannis" profiles | LinkedIn
Ioannis Kottakis MD,PhD,FCCP – Global Medical Head asthma – Novartis Pharma AG | LinkedIn
Effects of formoterol on exercise tolerance in severely disabled patients with COPD - Respiratory Medicine
10+ "Ioannis" profiles | LinkedIn
barndom Tveka Artificiell ioannis kottakis doctor - hawaiirealmedia.com
Ioannis 'John' Kottakis - Quality Assurance Engineer - Sword Group | LinkedIn
Ioannis Kottakis MD,PhD,FCCP – Global Medical Head asthma – Novartis Pharma AG | LinkedIn
Opsis Clinical | Medipass
